J, I., K, A., C, M., A, B., F, C., C, I., . . . A, B. (2025). Temocillin versus other intravenous beta-lactams for urinary tract infections caused by third-generation cephalosporin-resistant Enterobacterales: A multicentre retrospective matched cohort study. The Journal of antimicrobial chemotherapy, 80(12), 3329. https://doi.org/10.1093/jac/dkaf370
Chicago Style (17th ed.) CitationJ, Iachkine, Alexandre K, Marlat C, Briant A, Caron F, Isnard C, Verdon R, Parienti JJ, and Baldolli A. "Temocillin Versus Other Intravenous Beta-lactams for Urinary Tract Infections Caused by Third-generation Cephalosporin-resistant Enterobacterales: A Multicentre Retrospective Matched Cohort Study." The Journal of Antimicrobial Chemotherapy 80, no. 12 (2025): 3329. https://doi.org/10.1093/jac/dkaf370.
MLA (9th ed.) CitationJ, Iachkine, et al. "Temocillin Versus Other Intravenous Beta-lactams for Urinary Tract Infections Caused by Third-generation Cephalosporin-resistant Enterobacterales: A Multicentre Retrospective Matched Cohort Study." The Journal of Antimicrobial Chemotherapy, vol. 80, no. 12, 2025, p. 3329, https://doi.org/10.1093/jac/dkaf370.